Best Healthcare Stocks To Consider - January 13th

Key Points

• MarketBeat's stock screener highlights five Healthcare stocks to watch today: Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Hims & Hers Health (HIMS), and Tempus AI (TEM), which had the highest dollar trading volume among healthcare names in recent days.
• The report notes the healthcare sector is relatively defensive and is driven more by regulation, clinical-trial results, patent cycles, and demographic trends than by the broader economic cycle.
• These picks reflect a range of business models across the sector — from pharmaceuticals and MedTech (JNJ), health insurance and services (UNH/Optum), and surgical systems (ISRG) to telehealth (HIMS) and AI-enabled precision medicine (TEM).

Johnson & Johnson, UnitedHealth Group, Intuitive Surgical, Hims & Hers Health, and Tempus AI are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies involved in medical products and services — including pharmaceuticals, biotechnology, medical devices, healthcare providers and insurers. Investors use them to gain exposure to the healthcare sector, which is often relatively defensive and driven by regulation, clinical-trial results, patent cycles and demographic trends rather than only by the broader economic cycle. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Read Our Latest Research Report on JNJ

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

Intuitive Surgical (ISRG)

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read Our Latest Research Report on ISRG

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Read Our Latest Research Report on HIMS

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read Our Latest Research Report on TEM

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.